New study peers inside the eye to see how dry eye drugs really work
NCT ID NCT06898853
First seen May 09, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study looks at how a common anti-inflammatory eye drop (cyclosporin A) changes immune cells on the eye's surface in people with dry eye disease. Researchers will use a special microscope to watch these cells move and collect tear samples to measure inflammation. The goal is to better understand how the drug works, which could lead to improved treatments. The study involves 60 adults with dry eye and lasts 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
School of Optometry and Vision Science
RECRUITINGSydney, New South Wales, 2033, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.